- Report
- October 2024
- 140 Pages
Global
From €3544EUR$3,950USD£3,111GBP
- Report
- September 2024
- 150 Pages
Global
From €3455EUR$3,850USD£3,032GBP
€4352EUR$4,850USD£3,820GBP
- Report
- March 2024
- 79 Pages
North America
From €3096EUR$3,450USD£2,717GBP
- Report
- April 2023
- 115 Pages
Global
From €4262EUR$4,750USD£3,741GBP
- Report
- April 2023
- 147 Pages
Global
From €4441EUR$4,949USD£3,898GBP
- Report
- May 2023
- 147 Pages
Global
From €4441EUR$4,949USD£3,898GBP
- Report
- August 2024
- 200 Pages
Global
From €4441EUR$4,949USD£3,898GBP
- Report
- May 2024
- 160 Pages
Global
From €4459EUR$4,969USD£3,913GBP
- Report
- February 2024
- 72 Pages
Global
From €3585EUR$3,995USD£3,146GBP
- Report
- July 2024
- 184 Pages
Global
From €4482EUR$4,995USD£3,934GBP
- Report
- July 2024
- 157 Pages
Global
From €3242EUR$3,613USD£2,845GBP
€3814EUR$4,250USD£3,347GBP
- Report
- August 2024
- 150 Pages
Global
From €3455EUR$3,850USD£3,032GBP
€4352EUR$4,850USD£3,820GBP
- Report
- January 2024
- 150 Pages
Global
From €3455EUR$3,850USD£3,032GBP
€4352EUR$4,850USD£3,820GBP
- Report
- August 2024
- 268 Pages
Global
From €3230EUR$3,600USD£2,835GBP
- Report
- August 2024
- 135 Pages
Europe
From €1346EUR$1,500USD£1,181GBP
- Report
- August 2024
- 138 Pages
Asia Pacific
From €1346EUR$1,500USD£1,181GBP
- Report
- June 2022
- 242 Pages
Global
From €3230EUR$3,600USD£2,835GBP
- Report
- October 2024
- 70 Pages
Global
From €3585EUR$3,995USD£3,146GBP
- Report
- November 2025
Global
From €450EUR$537USD£409GBP
- Report
- November 2025
Global
From €450EUR$537USD£409GBP

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy.
The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes.
The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more